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Targeted Next-Generation Sequencing Appoints C16orf57
as Clericuzio-Type Poikiloderma with Neutropenia Gene
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Andrea Calabria,6 Maria Antonietta Mencarelli,7 Michele Fimiani,8 Fabio Macciardi,9 Rolph Pfundt,4
Eric F.P.M. Schoenmakers,4 and Lidia Larizza3,*
Next-generation sequencing is a straightforward tool for the identiﬁcation of disease genes in extended genomic regions. Autozygosity
mapping was performed on a ﬁve-generation inbred Italian family with three siblings affected with Clericuzio-type poikiloderma with
neutropenia (PN [MIM %604173]), a rare autosomal-recessive genodermatosis characterised by poikiloderma, pachyonychia, and
chronic neutropenia. The siblings were initially diagnosed as affected with Rothmund-Thomson syndrome (RTS [MIM #268400]),
with which PN shows phenotypic overlap. Linkage analysis on all living subjects of the family identiﬁed a large 16q region inherited
identically by descent (IBD) in all affected family members. Deep sequencing of this 3.4 Mb region previously enriched with array
capture revealed a homozygous c.504-2 A>C mismatch in all affected siblings. The mutation destroys the invariant AG acceptor site of
intron 4 of the evolutionarily conservedC16orf57 gene. Twodistinct deleteriousmutations (c.502A>Gand c.666_676þ1del12) identiﬁed
in an unrelated PN patient conﬁrmed that the C16orf57 gene is responsible for PN. The function of the predicted C16orf57 gene is
unknown, but its product has been shown to be interconnected to RECQL4 protein via SMAD4 proteins. The unravelled clinical and
genetic identity of PN allows patients to undergo genetic testing and follow-up.PN is an autosomal-recessive hereditary poikiloderma,
a clinically and genetically heterogeneous group of
disorders including RTS. The disorder is characterized by
skin manifestations, mainly a papular erythematous rash
starting on the limbs and face during the ﬁrst year of life
and evolving into poikiloderma with a pronounced acral
involvement, as well as pachyonychia, especially of the
toenails. One of the most important extracutaneous symp-
toms is an increased susceptibility to infections, mainly
affecting the respiratory system, primarily due to a chronic
neutropenia and to neutrophil functional defects. Bone
marrow abnormalities account for neutropenia and may
evolve into myelodysplasia associated with the risk of
leukemic transformation.1
PN shows phenotypic overlap with RTS, but a few
speciﬁc phenotypic differences point toward a distinct
genetic control. Mutations of RECQL4 (MIM *603780),
the helicase gene mutated in two thirds of RTS patients,
appear to be absent in PN patients.2,3,4
We genotyped a highly consanguineous Italian family
consisting of 29 subjects across ﬁve generations and
including three affected siblings (Figures 1A and 1B). The
affected members were initially misdiagnosed as RTS
patients as a result of the skin ﬁndings that appeared in
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and then evolving into classical poikiloderma. All siblings
also displayed pachyonychia, plantar keratoderma, and
dysmorphisms, especially those related to the midfacial
hypoplasia (Figure 1A). Severe neutropenia due to myelo-
dysplastic hemopoiesis led to recurrent pulmonary infec-
tions, otitis, and sinusitis in two siblings at early infancy.
All patients showed growth retardation, mild spleno-
megaly, and increased level of creatin kinase and lactate
dehydrogenase (LDH). Detailed family description, clinical
ﬁndings, neutrophil count, and testing and evolution
of the disease are reported by D.C. (unpublished data).
Concomitant acral poikiloderma, pachyonychia, and
chronic neutropenia, fairly unusual in RTS patients, were
more consistent with the PN diagnosis, which was further
supported by the absence of RECQL4 mutations (data not
shown). All sampled family members provided written
informed consent to participate in the study.
All living subjects (n¼ 18) were genotyped by a genome-
wide Affymetrix Genechip Human Mapping 262K NspI
SNPArray, and a two-point linkage analysis was performed
with SuperLink (v.1.6), assuming an autosomal-recessive
trait with 100% penetrance.5,6 SNPs were examined
for informative genomic regions that were homozygous
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siblings and were checked for quality control after removal
of ambiguous genotypes and data with a call rate under
a 95% threshold.
Linkage analysis identiﬁed three regions with a LOD
score > 2.5 (Figure 1C and Table S1, available online),
among which the 16q12.2-q21 region was selected as
the largest genomic interval of which consecutive LOD
score values never fall below 2 (Figure 1D). Indeed, the
expected length of the IBD-inherited region around the
disease locus is a function of the inbreeding coefﬁcient of
the proband. The inbreeding coefﬁcient of the last genera-
tion is 3/64, predicting a ~20 cM IBD region.7
The candidate16q region, spanning 3.4 Mb from SNP-
A_1803188 (rs16954293) to SNP-A_1923765 (rs9939133),
encompasses 276 consecutive SNPs, all consistent with
the predicted inheritance pattern, and contains more
than 80 known and predicted genes (Figure 1E). Such
a list of genes is notmanageable in the context of a classical
candidate-gene approach, thus prompting us to proceed
with array capture-mediated next-generation sequencing
(NGS), a strategy enabling an unbiased search for disease-
associated mutations in large genomic intervals.8
Theadopted stepwiseprocedure is detailed in Figure S1. In
brief, a genomic shotgun library from the3.4Mb16q region
of the siblings was prepared with paired-ends adapters in
accordance with Illumina guidelines. After quality control,
the library was captured by ImaGenes GmbH on a custom
repeats-masked 244K solid array (Agilent).
The target region, dropped from 3.4 Mb to 1.7 Mb
with this procedure, was eventually processed for NGS
(Solexa Technology). ELAND (Illumina GAPipeline 1.0)
mapping carried out against the full Homo sapiens genome
yielded the bed ﬁles that were visualized in the UCSC
Genome Browser, build March 2006 (Figure 1E). Mapping
with the Maq program (v.0.7.1)9 was carried out against
the selected 16q region. The best enrichment value (calcu-
lated according to the formula in Figure S1) was 241 for
patient V-2.
The reads were then aligned to the targeted reference
sequence, highlighting a total of 1488 mismatches: 450
were heterozygous mismatches that are unreported in
the UCSC database and are accounted for by their loca-
tion within DNA blocks with high sequence homology;
i.e., low copy repeats or duplicons in which chromosome
16 is enriched (UCSC Genome Browser). As regards
the homozygous mismatches, 494 have already been
reported and 527 lie within intergenic regions; therefore,
we focused over the remaining 17 unreported regions
located within or very close to genes. We ranked them
according to location and evolutionary conservation. As
shown in Table S2, the A>C SNP position (56.608.737)
appeared to be a strong candidate because it affects
the acceptor splice site of intron 4 of the highly con-
served C16orf57 gene (NM_024598.2) mapping to 16q13
(Figure 1E and Figure 2A); namely, the c.504-2 A>C
mutation destroys the invariant AG dinucleotide splice
acceptor (Figure 2B).The ADirect capillary sequencing conﬁrmed that themutation
segregates as expected across the last three generations,
and it also conﬁrmed the carrier (IV-6, IV-7, V-1, V-3) and
noncarrier (III-4, IV-2, IV-4, IV-5, IV-8) status of all the
living individuals within the pedigree. Subsequent cDNA
analysis on patient V-2 showed an aberrant transcript
106 nucleotides shorter as a result of exon 5 skipping
(Figures 2C and 2D). The predicted protein lacks 35 exon
5-encoded aminoacids and, because of frameshift, differs
from the original protein sequence in the following 61 resi-
dues (p.Thr169IleFsX61) (Figure S2B).
We tested ﬁve atypical RTS patients and validated the
association between C16orf57 and PN in the only patient
reported to have the PN clinical hallmark of neutropenia.
Indeed this nonrelated Italian female patient, who was
diagnosed with RTS andmyelodysplasia10 and tested nega-
tive for RECQL4mutations (data not shown), was found to
be a compound heterozygote for C16orf57 mutations. She
carries a paternally inherited c.666_676þ1del12 mutation
in exon 6 and a maternally inherited c.502A>G missense
mutation in exon 4, (Figure 2E). The c.502A>G mutation
is absent in 175 matched controls and affects a highly
conserved Arginine residue mapping within the conserved
HVSL domain of C16orf57. The comparative aminoacid
sequence analysis in HomoloGene and ClustalW showed
complete conservation at position p.R168 in several
eukaryotic species (Figure S3). cDNA analysis of the com-
pound heterozygous patient resulted in the identiﬁcation
of two aberrant transcripts (Figures 2F–2I) with the
in-frame skipping of exons 6 (paternal allele) and 4
(maternal allele). Mutated C16orf57 proteins lacking 28
(p.D204_Q231del) and 18 (p.F151_R168del) aminoacids
are predicted (Figures S2C and S2D).
Little is known about C16orf57 or the functions of its
encoded protein, but two independent studies revealed
direct interactions between the C16orf57 and SMAD4
proteins,11,12 which are interconnected to RECQL4
through HADAC1, TP53, and/or RAD51 (Figure S4). The
phenotypic overlap between RTS and PN can be partially
accounted for by SMAD4-mediated signaling of C16orf57
to RECQL4. The fact that C16orf57 is signiﬁcantly ex-
pressed in blood (myeloid lineage) might explain sensi-
tivity to C16orf57 mutations leading to neutropenia and
myelodysplastic features, which are distinctive signs of
PN patients (1–4 and D.C., unpublished data).
The identiﬁcation of a gene responsible for PN allows
one to test for the C16orf57 mutation in all RECQL4-nega-
tive RTS patients ﬁtting the PN clinical presentation, who
are probably misdiagnosed, in order to provide adequate
onco-hematological surveillance.
The presumptive role of C16orf57 in myeloid cell matu-
ration and function paves the way for investigation of the
contribution of this gene to both myelodysplasia and
congenital neutropenia syndromes. In addition, the high
degree of evolutionary conservation of C16orf57 increases
the chance that representative animal models can be
developed while such a line of research is pursued.merican Journal of Human Genetics 86, 72–76, January 8, 2010 73
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Figure 2. C16orf57 Mutational Analysis
(A) Schematic genomic structure of
C16orf57 (16q13) spanning 20 Kb and 7
exons (dark boxes), encoding a 265 aa
protein. Red arrows point to the identiﬁed
mutations (rimers and conditions reported
in Table S3).
(B and E) Pedigrees and sequencing of
C16orf57 genomic mutations: (B) shows
the carrier status of both parents and the
homozygous splicing mutation c.504-
2A>C of the three affected siblings, and
(E) the parental origin and the two muta-
tions c.666_676þ1del12 and c.502A>G
of the compound-heterozygous sporadic
patient. Base changes are indicated with
red characters.
(C, F, and H) Agarose gel electrophoresis,
showing products of different RT-PCR
(primers and conditions reported in Table
S4), on lymphoblastoid cell line RNA.
Lengths of normal and aberrant products
are indicated. The following abbreviations
are used: V-2, homozygous patient; P,
compound-heterozygous patient; Cþ,
normal control; C, negative control; M,
GeneRuler DNA Ladder Mix (Fermentas).
(D, G, and I) Sequence data of the two PN
patients showing aberrant transcripts
due to out-of-frame skipping of exon 5,
in-frame skipping of exon 6 and exon 4,
respectively, and related schematic
diagrams of the mutation-associated mis-
spliced cDNAs.Supplemental Data
Supplemental Data include four ﬁgures and four tables and can be
found with this article online at http://www.ajhg.org.Acknowledgments
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